David Arthur Woodrum1, Lance Mynderse2,
Akira Kawashima1, Krzysztof Gorny1, Thomas Atwell1,
Fred Mcphail2, Bradley Bolster3, Wesley Gilson3,
Kimberly Amrami1, Haraldur Bjarnason1, Matthew
Callstrom1
1Radiology, Mayo Clinic, Rochester, MN,
United States; 2Urology, Mayo Clinic, Rochester, MN, United
States; 3Siemens Medical Solutions, Inc.
Prostate
cancer recurrence after definitive therapy can be as high as 25% after 15
years. Detection of these recurrences can be achieved using serial PSA
coupled with dynamic contrast enhanced (DCE) MRI. Our hypothesis is MR-guided cryoablation
can be used in the setting of prostate bed PAC recurrence to perform a
precise image-guided focal ablation.
Two patients with prior RRP and dynamic contrast enhancement(DCE) MRI
abnormalities in the prostate bed were treated using MR-guided cryoablation.
Both patients with recurrent prostate cancer in the prostate bed were
successfully treated with MR-guided cryoablation. Immediate post-ablation DCE
MRI demonstrated no definite residual tumor.